PRTC — Puretech Health Cashflow Statement
0.000.00%
Last trade - 00:00
- £579.04m
- £312.90m
- $15.62m
- 29
- 11
- 90
- 36
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -70.7 | 366 | 4.57 | -62.7 | -37.1 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | -16.6 | -599 | -112 | -72.8 | -146 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 9.96 | 16.2 | -30.8 | -30.1 | -4.68 |
Change in Accounts Receivable | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -72.8 | -98.2 | -132 | -158 | -179 |
Capital Expenditures | -4.49 | -12.5 | -5.42 | -5.66 | -2.18 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | -35.2 | 76.2 | 370 | 203 | -105 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -39.6 | 63.7 | 364 | 197 | -107 |
Financing Cash Flow Items | -1.07 | -1.28 | -12.9 | -14.1 | -0.041 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 157 | 49.9 | 38.9 | 22.7 | -29.8 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 44.4 | 15.3 | 272 | 61.8 | -316 |